Training & Education View post tag: News by topic View post tag: Youth View post tag: Lessons View post tag: share View post tag: Guam View post tag: sailors USS Fitzgerald Sailors Share Lessons with Guam Youth October 2, 2012 Sailors from USS Fitzgerald (DDG 62) discussed the importance of school, careers and a drug-free attitude to students at Okkodo High School in Dededo Sept. 26.The outreach to the school was one of two community service projects Fitzgerald Sailors supported during a port call on Guam.“I think it’s a great contact for [students] and to give them more information one-to-one and face-to-face, so they have more comfort level with approaching people in the military and getting to understand what the military is about, especially here on Guam,” said Okkodo High School business education teacher Sharon Baxter.During their visit, Sailors answered questions about life-enrichment, education and life as a Navy Sailor.“It’s always important to come out and talk to kids,” said Operations Specialist 1st Class (SW) Justen Abernethy. “Especially because it’s the time of period when they’re starting to take everything in and they’re learning and they’re adapting to that adult life. So it’ll help them along their path if they can hear it from the people who are out there, doing the job itself.”Abernethy added that discussing leadership and opportunities with students could make differences in their futures.“The benefits for them is just that much more knowledge, that much more understanding and being able to say, ‘Hey, this is why they do this and I can do this and I can be that much better in my life.’”Seaman Recruit Mark Christian agreed with Abernethy and said that the Navy is a great career for students to look to help better themselves. “I wish somebody did it to me, to be honest with you,” he said. “I wish I had somebody to come there and answer questions. There’s a lot of good things the Navy can offer.”Sailors also supported Special Olympics of Guam, coaching bowling athletes Sept. 29 at Century Lanes in Tamuning in preparation for an upcoming tournament.[mappress]Naval Today Staff,October 2, 2012 Back to overview,Home naval-today USS Fitzgerald Sailors Share Lessons with Guam Youth View post tag: Navy View post tag: Naval View post tag: Fitzgerald Share this article
Back to overview,Home naval-today NUSHIP Adelaide Ready to Enter the Fleet View post tag: NUSHIP Adelaide December 2, 2015 Royal Australian Navy began preparations for the commissioning of its second Landing Helicopter Dock (LHD), NUSHIP Adelaide, which will take place Friday, December 4.The 400 crew members of the Amphibious Assault Ship are readying themselves for this occasion.Adelaide is the second of two Landing Helicopter Docks (LHDs) to be commissioned and marks the transformation of Australian Defence Force capability. She joins her sister ship Canberra in service.The LHDs will be employed in different roles and can be configured to suit different missions. The world class amphibious capability can undertake a broad spectrum of operations from humanitarian assistance and disaster relief, security and stability operations across the Indo-Pacific region, to defence of the nation.Adelaide can embark, transport and deploy an embarked force along with their equipment and aviation units. More than 1,000 embarked forces can be landed ashore by landing craft, helicopters, or a combination of both. She has a medical facility equipped with two operating theatres, an eight bed Critical Care Unit, and a variety of wards.In addition, the medical facility has dedicated areas to accommodate pathology and radiology services, x-ray, pharmacy and dental facilities.[mappress mapid=”17483″]Image: Royal Australian Navy Authorities NUSHIP Adelaide Ready to Enter the Fleet View post tag: Royal Australian Navy Share this article
Twitter Latest word about coronavirus cases from Indiana State Department of Health Hoosiers are urged to be on alert for phishing scams or fraudulent emails, especially those pretending to be from the CDC or offering testing or vaccination, and verify that any charity seeking your assistance is legitimate before donating. Consumers who believe they may have been the victim of a scam can contact the Indiana Attorney General’s Office at https://www.in.gov/attorneygeneral/2434.htm.The CDC has issued guidance regarding cleaning surfaces in a household with a resident who is suspected or confirmed to have COVID-19. Pinterest Facebook (Photo supplied/Indiana State Department of Health) The number of Hoosiers who have tested presumptively positive for COVID-19 remains unchanged at 12 as announced earlier today by Indiana State Department of Health. This number reflects tests performed at ISDH, the Centers for Disease Control and Prevention and those submitted by private laboratories.The individuals with positive tests reside in Marion, St. Joseph, Hendricks, Adams, Boone, Howard, Johnson and Noble counties. All but one are adults.ISDH continues to work with local health departments to identify close contacts of the existing patients and ensure that infection-control protocols, such as self-isolation and monitoring for symptoms, are implemented.Other developments:The ISDH lab has received additional testing supplies from the CDC and continues to prioritize individuals who are at high risk.Individuals who do not meet those criteria are encouraged to consult their healthcare provider about private testing. Most people with COVID-19 will develop mild symptoms and do not need to be tested. WhatsApp By 95.3 MNC – March 14, 2020 0 262 Pinterest Google+ The ISDH call center is experiencing extremely high call volume, receiving more than 1,000 calls from 8 a.m. Thursday to 8 a.m. Friday.The ISDH general call center number is 317-233-7125. Calls after 8 p.m. should go to 317-233-1325 and will be answered by an on-call epidemiologist. Call center staff will not offer personal medical advice or provide test results. If you are sick, consult your healthcare provider. The Indiana Family and Social Services Administration’s Division of Mental Health and Addiction has posted guidance for mental health providers to help them assist Hoosiers during this outbreak. The guidance can be found here. The CDC also is providing guidance for individuals who are having difficulty coping during this time.Since Jan. 28, 142 Indiana travelers have been monitored for symptoms of COVID-19, which include cough, fever and shortness of breath, due to recent travel to an impacted country.Hoosiers are encouraged to continue to sign up at https://on.in.gov/COVID19 to receive alerts and the latest updated guidance as the outbreak evolves WhatsApp Google+ CoronavirusIndianaLocalNews Twitter Facebook Previous articleMayor Mueller send questions to special prosecutor in charge of Eric Logan shootingNext articleMichigan coronavirus cases hit 25 as restrictions tighten 95.3 MNCNews/Talk 95.3 Michiana’s News Channel is your breaking news and weather station for northern Indiana and southwestern Michigan.
Aryzta has made new independent board appointments to help turn the business around, and announced that banks have agreed to underwrite plans to raise €800m (£715m) through a new share offer.Former McDonald’s USA president Michael Andres is among three new appointments subject to approval at the company’s AGM on 1 November.Andres spent the majority of his career with McDonald’s, joining in 1982 and most recently serving as president of the business’ largest global division. He previously served in senior positions at McDonald’s, and led the turnaround and sale of restaurant chain Boston Market.Also joining the board are Gregory Flack, who was CEO of Schwan Food Company from 2008 until 2013; and Tim Lodge, who spent most of his career at Tate & Lyle where he was CFO from 2008 until 2014.“We are pleased to announce the nomination of three new directors,” said Aryzta chairman Gary McGann. “Each brings significant and diverse industry experience, which will be invaluable to the board as we deliver on what is a multi-year turnaround.”In plans announced last month, Aryzta will approach shareholders with a view to raising £715m in additional funding that will be used primarily to reduce debt. Aryzta said this would give it flexibility to implement its business plan and focus on the frozen bakery market.The company has entered into a standby volume underwriting agreement with BofA Merrill Lynch, UBS, Credit Suisse, JP Morgan and HSBC. Aryzta has also received consent from lenders to amend its existing facilities agreement to provide additional flexibility to pursue its business strategy.The move follows a profit warning in May and announcement of plans to reduce costs over the next three years as the business comes under pressure from increased labour and ingredient costs.Aryzta has previously announced a €1bn deleveraging plan, made up of a combination of cash flow generation and at least €450m of asset disposals, including the planned sale of French retail group Picard.“A significantly improved capital structure will provide Aryzta with the means to continue to take the necessary steps to reposition the business and deliver on our strategy,” said Aryzta chief executive Kevin Toland.
John Mayer dropped by YouTube’s First We Feast channel to join host Sean Evans for the season finale of Hot Ones. If you’re unfamiliar, Hot Ones is a fascinating show with a fairly simple premise: Evans interviews celebrities while they eat chicken wings covered in a variety of hot sauces. The kicker is that only some of these hot sauces could be described as garden variety. You see, while the banter stays cordial throughout the interview, the sauces get progressively spicier.How spicy do the sauces get, you ask? Well, your average Tabasco sauce clocks in at roughly 2,000 Scovilles (science’s preferred unit of spice measurement). But the final Hot Ones sauce that Evans forces his guests to consume? That stuff is 2,000,000 Scovilles—literally a thousand times stronger.Anyway, Mayer’s descent in the into the deepest depths of hot wing hell is pretty darn entertaining. Partially because of the spice factor, but mostly because of the conversation. Over the course of 20 minutes, the pair dives into topics like Dave Chapelle, Justin Bieber, life in Montana, and, of course, rock’s greatest guitar faces. Finally, the whole thing reaches its climax with little ukulele jam before Mayer wraps things up with a request for people who wear Grateful Dead shirts but don’t know any of the band’s songs. You can check it all out below.Hot Ones with John Mayer [Video: First We Feast]
According to the 2016 World Economic Forum report, the following jobs did not exist in 2006:Big Data Analyst / Data ScientistCloud Computing SpecialistDriverless Car EngineerIOT DeveloperSocial Media Manager It is no stretch to say that these jobs are the result of a massive jump in the production, curation and consumption of data. A large digital ecosystem is continuously expanding to support these trends. Large multi-billion dollar industries have sprung up in this digital era and are, perhaps, irrevocably changing how we interact with the real world.Enterprises, big and small, are having to deal with a digital overload within (and without) their businesses. While they always had traditional IT infrastructure to support traditional financial, CRM or Logistics applications, they are quickly getting overwhelmed with the deluge of data. There is a huge computational capability issue. Take, for example, retailers who are striving determine:Who is shopping?What do customers prefer to buy?How to positively influence customer buying patterns?How to make a customer more loyal?Retailers are employing sophisticated machine-learning approaches to answer some of these thorny questions. These retailers not only need a vast, interconnected system but also need a secure, powerful IT infrastructure that has the computational horsepower and efficiency to employ machine learning algorithms to provide these insights.More and more of the functional processes in large enterprises are undergoing digitization. This results in higher volume of data coming into the traditional systems at a higher velocity. Just being able to manage large data is no longer sufficient. It is about using all that data to answer questions that deliver insights into business operations, customer preferences or marketing opportunities. It is about performing insightful data analytics faster.Emerging workloads such as machine learning or data analytics require high computational capability combined with large capacity. This combination helps drive consistent but rapid results. However, traditional IT systems are struggling just to keep up, let alone deliver insights in an adequate amount of time. Business leaders are increasingly frustrated with these traditional systems that are not scalable with current business demands.Enter the “Zoom Zoom” box.Dell EMC has been working with customers for many years to help solve their pressing IT challenges and improve business outcomes. As enterprises drown in data, Dell EMC has come up with an innovative yet simple approach to this problem – Make faster servers with more capacity. Four sockets. And more accelerators. More zoom zoom!Today, Dell EMC is announcing the availability of two new four-socket servers – the PowerEdge R940xa and PowerEdge R840, part of the 14th generation Dell EMC PowerEdge server portfolio.The servers allow customers to:Rapidly transform data insights into business outcomes with the Dell EMC PowerEdge R940xa, which is designed to accelerate databases for business-critical applications.Drive faster insights to better engage with customers and accelerate innovation with the Dell EMC PowerEdge R840 server, which is designed for in-database analytics.With extensive performance density (up to 112 processing cores) and massive memory (up to 6TB of memory and NVDIMM options), these new servers deliver the necessary powerful performance. In fact, the PowerEdge R840 holds the four-socket world record for SAP SD standard benchmark of 65,900 users+. The PowerEdge R940xa lets you accelerate critical workloads with a 1:1 CPU to GPU ratio and up to four double-width GPUs. The R840 offers up to two double-width GPUs in addition to up to 24 NVMe drives for some “serious” speed. Additionally, these servers also support field programmable gate arrays (FPGAs), which excel on data-intensive computations. The R940xa offers up to eight FPGAs while the R840 offers up to two FPGAs, so you can tailor your workload acceleration requirements.Beyond offering accelerated performance and high capacity, both servers feature OpenManage Enterprise to monitor and manage the IT infrastructure. An agent-free Integrated Dell Remote Access Controller (iDRAC) provides automated, efficient management to improve productivity. Additionally, Dell EMC PowerEdge’s Integrated Security features such as the Cyber Resilient Architecture come standard within every server.See how Richard Heyns, CEO of Brytlyt looks at these complex computational challenges and how his company is using PowerEdge R940xa to provide better business outcomes faster.Learn more about the complete PowerEdge portfolio at dellemc.com/Servers. Join the conversation at @DellEMCservers.+ Results of the Dell EMC PowerEdge R840 on the two-tier SAP SD standard application benchmark 65,900 Users; SAP benchmark with enhancement package 5 for SAP ERP 6.0, SAP ASE 16; SLES12SP3: with Intel Xeon Platinum 8180M CPUs (4 CPUs, 112 cores and 224 threads) and 1536GB of memory. Certification number: 20180xx. Results as of April 2018. For more details see http://sap.com/benchmarks
By Yuvinka Gozalvez Avilés / Voice of America January 21, 2020 On January 8, Bolivian Communication Minister Roxana Lizárraga said that about 700 presumed Cuban doctors, who were working in Bolivia as part of a health agreement signed by former President Evo Morales, weren’t qualified to practice, because they lacked the necessary degrees or had fraudulent ones, and that their true mission in the South American nation was intelligence work.“We waited for the right time to disclose that part of this team coming from Cuba weren’t doctors, they didn’t practice as doctors […]. We were able to confiscate several of their degrees that were forged to make it seem as if they were doctors,” said Lizárraga.The minister added that Morales’ distrust in Bolivian authorities led him to put the security of the Bolivian State in the hands of Cubans and Venezuelans, and that the economic damage to the country was high.“The economic damage is enormous, because there was no investment in health. There were investments to fund intelligence personnel,” Lizárraga said.Bolivian Health Minister Aníbal Cruz attended the press conference where the information was revealed. He said he had physical evidence (documents, videos, and photographs) that backed the accusations.Cruz said that these alleged doctors had “objectives that were more about indoctrination […], using an excessive amount of assets and budget.” He added that citizens were the ones most affected since health is a critical matter.At the end of 2019, Bolivian Interior Minister Arturo Murillo said that authorities had caught four presumed Cuban doctors with about $100,000, money that, according to local authorities, would have been used to fund riots in Bolivia. Havana said the money was meant for the medical mission’s payroll and rent.Days later, Cuban authorities announced in a press release the withdrawal of 700 doctors from Bolivia, alleging that they were targets of attacks by the interim government of President Jeanine Áñez.
To say that employers have had a difficult task in planning for employee health benefits is an understatement. Between the landmark passage of the Affordable Care Act, the increasing costs of benefits, and the residual effects of a recession, today’s health care spectrum has become riddled with complexities and unprecedented challenges.Like many other employers, credit unions aren’t immune to these economic concerns, specifically the rising costs of benefits. According to a survey by the Kaiser Family Foundation and Health Research and Education Trust, the average annual premium for employer-provided family health care coverage in 2014 was $16,834, which is about 69% higher than the average of $9,950 from 2004. Not to mention, these increasing costs are being aggravated by another challenge: falling investment returns.These trends would be unsettling to any credit union. But, could there be a viable solution? Yes, and it’s called benefits pre-funding. In a nutshell, pre-funding allows credit unions to increase their investment returns to help offset the cost of employee benefits. How exactly is pre-funding an option? continue reading » 8SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr
Feb 16, 2007 (CIDRAP News) – The live-virus, intranasal influenza vaccine FluMist strongly outperformed conventional killed-virus vaccines in a study involving close to 8,000 children younger than 5 years, a finding that may help pave the way for US approval of the vaccine for that age-group.In the international trial conducted in the 2004-05 flu season, there were almost 55% fewer cases of flu in children who received FluMist than in those who received the conventional injectable vaccine, according to a report published in the Feb 15 New England Journal of Medicine (NEJM). The live vaccine worked better than the conventional ones regardless of how well the vaccines matched the circulating viruses.”It’s a pretty convincing result,” commented vaccine expert John Treanor, MD, of the University of Rochester (New York), who was not involved in the research.On the downside, 6- to 11-month-old children in the FluMist group had significantly more hospitalizations for any reason after vaccination and also had a few more episodes of wheezing than their counterparts in the other group.FluMist is currently licensed for use in healthy people between the ages of 5 and 49. On the basis of their findings, the authors, led by Robert B. Belshe, MD, of St. Louis University, conclude that the vaccine is effective and safe for children from 12 to 59 months old with no history of asthma or wheezing.The Centers for Disease Control and Prevention (CDC) currently recommends annual flu vaccination for children from 6 through 59 months old, among other groups considered to have an increased risk of serious complications from flu. Only inactivated, injectable vaccines are licensed for that age-group.FluMist, made by MedImmune Inc., based in Gaithersburg, Md., has been on the market since 2003, but demand for it has been hampered by a higher cost than conventional vaccine and by the requirement to keep it frozen during storage. Last month the Food and Drug Administration (FDA) approved a new formulation that requires refrigeration but not freezing. The refrigerator-stable formulation was used in the new study.MedImmune, which sponsored the study, submitted preliminary results to the FDA in July 2006 with a request to permit use of the vaccine in children aged 1 through 4 years with no history of wheezing, according to Jamie Lacey, a company spokeswoman in Gaithersburg. She called the study “the pivotal trial” supporting the request.The company expects to hear an initial response from the FDA by May 28, Lacey told CIDRAP News. “We’re prepared for approval of this expanded indication for next [flu] season. That’s what we’re gearing up for,” she said.Study included 16 countriesThe study involved 249 physcians’ offices and clinics in 16 countries, with about half of the sites in the United States. The researchers recruited more than 8,300 children, of whom 7,852 completed the study. Children with a history of severe asthma or a recent history of wheezing were excluded, but those with mild or moderate asthma were included.Both FluMist and the injectable vaccines used in the trial, made by Aventis Pasteur, contained the three virus strains recommended by the FDA for the 2004-05 season. In equal numbers, children were randomly assigned to receive either FluMist or the injectable vaccine, and each participant also received a placebo version of the other vaccine (FluMist recipients received dummy injections, and injectable-vaccine recipients received a placebo dose of nasal spray). Participants and medical workers were blinded to the treatment assignments.The researchers reported 153 cases of flu in the FluMist group, for an attack rate of 3.9%. This was 54.9% lower than the 338 cases in the conventional vaccine group, with an attack rate of 8.6% (P<.001). For culture-confirmed flu cases, the attack rates were 5.0% for the FluMist group and 10.0% for the inactivated vaccine group.The live vaccine worked well against both well-matched and mismatched flu strains. Compared with the inactivated-vaccine group, the FluMist group had 89.2% fewer cases of influenza A/H1N1, a strain for which the vaccine was well-matched, and 79.2% fewer cases of A/H3N2, which the vaccine did not match well, the report says. Both differences were significant.The 2004-05 season saw several strains of influenza B, of which some matched the vaccine and some did not. The FluMist group had 16.1% fewer cases of type B flu than the other group, a nonsignificant difference.As for vaccine safety, 6.1% of FluMist recipients between 6 and 11 months old were hospitalized for any cause within 180 days after vaccination, versus 2.6% of children in that age range who received inactivated vaccine, a significant difference. There was no significant difference in hospitalization rates between the two groups overall.The investigators also noted that among children who had a history of wheezing, there was a trend toward a higher rate of all-cause hospitalization among 6- to 47-month-olds in the FluMist group, though it was not significant.The researchers found no significant difference between the two groups in the overall rate of wheezing episodes. But among previously unvaccinated children, 3.8% of FluMist recipients aged 6 to 11 months had a wheezing episode within 42 days after their first vaccine dose, as compared with 2.1% of the same age-group among inactivated vaccine recipients (P=.076). The episodes occurred in the second, third, and fourth weeks after vaccination, after the peak of viral replication, the report says.Overall, the authors write, the findings suggest that FluMist can play an important role in controlling flu. "On the basis of our results, the risk-benefit ratio for live attenuated vaccine appears favorable among children 12 to 47 months of age who have no history of wheezing."Until additional data are available, the observations related to medically significant wheezing and rates of hospitalization will restrict the use of live attenuated vaccine in children younger than 1 year and in children 12 to 47 months of age who have a history of asthma or wheezing," the report states.Though 'definitive,' study lacked placebo groupTreanor, a veteran vaccine researcher and professor of medicine, microbiology, and immunology, commented, "I think one of the things about the study that's remarkable is how carefully done it was and its size. It's quite definitive."He said the study strengthens his general impression that the immune response to live attenuated flu vaccines varies with age. "It really does look like younger children support the replication of the cold-adapted [intranasal] virus more than do adults," leading to a stronger immune response, he commented.Evidence about immune responses and the ability of the vaccine virus to replicate in the nose suggests that the live vaccine probably works better than inactivated vaccine in children, Treanor said. In young and middle-aged adults it appears that the two types are roughly equivalent, though the live vaccine may be slightly better, while inactivated vaccine seems to work better in elderly people, he added."This all reflects the impact of the host on the ability of the live vaccine to replicate and induce an immune response," Treanor said. He said the immunogencity of live vaccines "starts to tail off as you get older and have been exposed to the flu many times," though it's not clear where the age boundaries are.Treanor also commented that in the FluMist study, the flu attack rate of 8.6% in the inactivated-vaccine group is "a reminder that flu vaccines are not perfect in young kids."One limitation of the FluMist study is that the investigators "did not feel they should include a placebo group," Treanor said. That limits the ability to assess the relative benefits of FluMist and the conventional vaccine as compared with no vaccine—a point also made in a NEJM editorial by Nancy J. Cox, PhD, and Carolyn Buxton Bridges, MD, of the CDC."It's hard to have a placebo group in a population where a vaccine is already recommended as a routine step," Treanor said. "But this gap in the knowledge will make it harder for policy makers."For example, he said, the CDC's Advisory Committee on Immunization Practices may eventually want to consider making a specific recommendation about the use of FluMist in small children. Given the likelihood of cost differences and safety issues to consider, "the lack of a placebo group will make that decision more difficult," he said.In their editorial, Cox and Bridges say the live attenuated vaccine may offer "significant advantages" for children, because it doesn't involve needles and may provide better protection against flu than conventional vaccines do."However, enthusiasm for the vaccine must be tempered" by the signs of an increased risk of wheezing and of hospitalization in children less than 1 year old, they write. Although the results are "encouraging, further discussion and careful review of the safety data" will be necessary before policy decisions are made, they add.Belshe RB, Edwards KM, Vesikari T, et al. Live attenduated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007 Feb 15;356(7):685-96 [Abstract]Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children—how do they compare? (Editorial) N Engl J Med 2007 Feb 15;356(7):729-31See also:Jan 9, 2007, CIDRAP News story "FDA approves refrigerated form of FluMist"
Michalik will oversee Germany and Austria. Sven Simonis leads the institutional business in this area, with Hagen Schremmer in charge of retail.Manuel Faccio, previously CEO of DWS in Switzerland, is now head of southern Europe, France and MENA. Reporting to him are: Olivier Dubost, responsible for France and MENA; Mauro Castiligioni, head of Italy; Mariano Arenillas, covering Spain; and Pascal Imhof for Switzerland.Elsewhere, Sandra Niethen has been appointed head of institutional and client strategy, including consultant relations and pension advisory services. She was previously chief of staff.Michalik told staff that the changes were part of DWS’ “strategic ambitions” and were aimed at “creating an efficient coverage model that has clearly-defined responsibilities”.Yesterday, DWS reported an 18% increase in profits before tax in the third quarter of 2018, compared with the previous three months. The group’s assets under management grew by €5bn, with market performance offsetting client withdrawals of €2.7bn.This week the group also announced an extension of its partnership with Italian insurance giant Generali to provide unit-linked insurance products via Generali’s networks in France, Switzerland, Italy and Germany.The deal followed a partnership announced last week between DWS and French investment house Tikehau specialising in alternatives. DWS has reshuffled senior staff roles in the wake of its IPO earlier this year, creating a number of regional leadership roles.The €692bn asset manager told staff this week of the changes, which involved grouping individual country heads into four regions: northern Europe, southern Europe with the Middle East and north Africa (MENA), Asia Pacific, and Germany and Austria.In a note to staff seen by IPE, Thorsten Michalik, head of coverage at DWS, said: “This streamlined structure is designed to provide a more consistent global operating model that will foster greater communication between our various teams.”Effective this week, Maria Ryan, head of UK, has taken on additional responsibility for the Nordic and Benelux regions, with head of Nordics Thomas Lindahl and head of Benelux Pieter Furnee reporting to her.